BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30523156)

  • 21. AMP-activated kinase reciprocally regulates triacylglycerol synthesis and fatty acid oxidation in liver and muscle: evidence that sn-glycerol-3-phosphate acyltransferase is a novel target.
    Muoio DM; Seefeld K; Witters LA; Coleman RA
    Biochem J; 1999 Mar; 338 ( Pt 3)(Pt 3):783-91. PubMed ID: 10051453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thioesterase superfamily member 2 (Them2)/acyl-CoA thioesterase 13 (Acot13): a homotetrameric hotdog fold thioesterase with selectivity for long-chain fatty acyl-CoAs.
    Wei J; Kang HW; Cohen DE
    Biochem J; 2009 Jun; 421(2):311-22. PubMed ID: 19405909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased oxidative stress is associated with balanced increases in hepatocyte apoptosis and proliferation in glycerol-3-phosphate acyltransferase-1 deficient mice.
    Hammond LE; Albright CD; He L; Rusyn I; Watkins SM; Doughman SD; Lemasters JJ; Coleman RA
    Exp Mol Pathol; 2007 Apr; 82(2):210-9. PubMed ID: 17258706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
    Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on glycerol-3-phosphate acyltransferases: the roles in the development of insulin resistance.
    Yu J; Loh K; Song ZY; Yang HQ; Zhang Y; Lin S
    Nutr Diabetes; 2018 May; 8(1):34. PubMed ID: 29799006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.
    Jornayvaz FR; Birkenfeld AL; Jurczak MJ; Kanda S; Guigni BA; Jiang DC; Zhang D; Lee HY; Samuel VT; Shulman GI
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5748-52. PubMed ID: 21436037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibited insulin signaling in mouse hepatocytes is associated with increased phosphatidic acid but not diacylglycerol.
    Zhang C; Hwarng G; Cooper DE; Grevengoed TJ; Eaton JM; Natarajan V; Harris TE; Coleman RA
    J Biol Chem; 2015 Feb; 290(6):3519-28. PubMed ID: 25512376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ.
    Guo H; Li D; Ling W; Feng X; Xia M
    J Lipid Res; 2011 May; 52(5):908-22. PubMed ID: 21343633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
    Popov VB; Jornayvaz FR; Akgul EO; Kanda S; Jurczak MJ; Zhang D; Abudukadier A; Majumdar SK; Guigni B; Petersen KF; Manchem VP; Bhanot S; Shulman GI; Samuel VT
    FASEB J; 2016 Mar; 30(3):1207-17. PubMed ID: 26644352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
    Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
    Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice.
    Stout MB; Liu LF; Belury MA
    Mol Nutr Food Res; 2011 Jul; 55(7):1010-7. PubMed ID: 21480517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 6-Gingerol Ameliorates Hepatic Steatosis via HNF4α/miR-467b-3p/GPAT1 Cascade.
    Ahn J; Lee H; Jung CH; Ha SY; Seo HD; Kim YI; Ha T
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1201-1213. PubMed ID: 34139323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
    Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
    Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol protects against hepatic insulin resistance in a rat's model of non-alcoholic fatty liver disease by down-regulation of GPAT-1 and DGAT2 expression and inhibition of PKC membranous translocation.
    Badi RM; Mostafa DG; Khaleel EF; Satti HH
    Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):545-555. PubMed ID: 30773673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
    Zhang D; Liu ZX; Choi CS; Tian L; Kibbey R; Dong J; Cline GW; Wood PA; Shulman GI
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17075-80. PubMed ID: 17940018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis of the acyl-transfer mechanism of human GPAT1.
    Johnson ZL; Ammirati M; Wasilko DJ; Chang JS; Noell S; Foley TL; Yoon H; Smith K; Asano S; Hales K; Wan M; Yang Q; Piotrowski MA; Farley KA; Gilbert T; Aschenbrenner LM; Fennell KF; Dutra JK; Xu M; Guo C; Varghese AE; Bellenger J; Quinn A; Am Ende CW; West GM; Griffor MC; Bennett D; Calabrese M; Steppan CM; Han S; Wu H
    Nat Struct Mol Biol; 2023 Jan; 30(1):22-30. PubMed ID: 36522428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis.
    Monsénégo J; Mansouri A; Akkaoui M; Lenoir V; Esnous C; Fauveau V; Tavernier V; Girard J; Prip-Buus C
    J Hepatol; 2012 Mar; 56(3):632-9. PubMed ID: 22037024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.
    Nicholls HT; Hornick JL; Cohen DE
    Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G50-G61. PubMed ID: 28385694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial glycerol-3-P acyltransferase 1 is most active in outer mitochondrial membrane but not in mitochondrial associated vesicles (MAV).
    Pellon-Maison M; Montanaro MA; Coleman RA; Gonzalez-Baró MR
    Biochim Biophys Acta; 2007 Jul; 1771(7):830-8. PubMed ID: 17493869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.